Twist Bioscience Corp. (TWST)
182.90
-1.14
(-0.62%)
USD |
NASDAQ |
Sep 25, 16:00
184.49
+1.60
(+0.87%)
After-Hours: 19:59
Twist Bioscience Research and Development Expense (Annual) : 80.28M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 80.28M |
| September 30, 2024 | 90.85M |
| September 30, 2023 | 106.89M |
| September 30, 2022 | 120.31M |
| September 30, 2021 | 69.07M |
| Date | Value |
|---|---|
| September 30, 2020 | 43.01M |
| September 30, 2019 | 35.68M |
| September 30, 2018 | 20.35M |
| September 30, 2017 | 19.17M |
| September 30, 2016 | 18.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 379.09M |
| Beam Therapeutics, Inc. | 409.62M |
| Absci Corp. | 80.72M |
| Prime Medicine, Inc. | 160.64M |
| Generate Biomedicines, Inc. | 211.63M |